MediTrace, a company developing systems for medical device production traceability, has secured $4.2M in seed funding. The capital injection arrives as manufacturers face increasing pressure to meticulously track their products from raw materials to market, ensuring both quality and regulatory compliance. MediTrace's platform aims to streamline this complex process, offering a dedicated solution for an industry where precision and accountability are paramount. This initial investment will help the company scale its technology and reach more device makers.

















